BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17967799)

  • 1. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 2. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
    Sam R; Wu H; Yue L; Mazzone T; Schwartz MM; Arruda JA; Dunea G; Singh AK
    Am J Kidney Dis; 2006 Mar; 47(3):539-48. PubMed ID: 16490634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
    Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T; Matsunaga A; Oikawa S
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
    Han HL; Lin S; Sun LS; Zhang P; Zhai DP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
    Saito T; Matsunaga A
    J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants.
    Saito T; Oikawa S; Sato H; Sasaki J
    Nephron; 1999; 83(3):193-201. PubMed ID: 10529625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipoprotein glomerulopathy].
    Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():353-60. PubMed ID: 11347095
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
    J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein glomerulopathy].
    Saito T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():112-6. PubMed ID: 17899837
    [No Abstract]   [Full Text] [Related]  

  • 13. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
    Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W
    J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.
    Toyota K; Hashimoto T; Ogino D; Matsunaga A; Ito M; Masakane I; Degawa N; Sato H; Shirai S; Umetsu K; Tamiya G; Saito T; Hayasaka K
    J Hum Genet; 2013 May; 58(5):254-8. PubMed ID: 23407349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population.
    Yang AH; Ng YY; Tarng DC; Chen JY; Shiao MS; Kao JT
    Nephron; 1998; 78(3):266-70. PubMed ID: 9546684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.
    Wang R; Zhao C; Chen W; Liu Z; Xie F
    J Med Case Rep; 2022 Feb; 16(1):78. PubMed ID: 35193676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of endothelial cells and triglyceride-rich lipoproteins with apolipoprotein E (Arg-->Cys) from a patient with lipoprotein glomerulopathy.
    Murano T; Matsumura R; Misawa Y; Ozaki H; Miyashita Y; Yoshida S; Sueioshi M; Sugiyama T; Shirai K
    Metabolism; 2002 Feb; 51(2):201-5. PubMed ID: 11833049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
    Xie W; Xie Y; Lin Z; Xu X; Zhang Y
    Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E and renal disease.
    Liberopoulos E; Siamopoulos K; Elisaf M
    Am J Kidney Dis; 2004 Feb; 43(2):223-33. PubMed ID: 14750087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E-related glomerular disorders.
    Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.